共 14 条
[1]
A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer’s disease. Imbimbo BP,Lucca U,Lucchelli F,et al. Alzheimer Disease and Associated Disorders . 1998
[2]
The effects of donepezil in Alzheimer’s disease- results from a multinational trial. Burns A,Rossor M,Hecker J,et al. Dementia and Geriatric Cognitive Disorders . 1999
[3]
A controlled study of two doses of idebenone in the treatment of Alzheimer’s disease. Weyer G,Babej-Dolle RM,Hadler D,et al. Neuro- psychobiology . 1997
[4]
Safety of tacrine: clinical trials, treatment IND, and postmarketing experience. Gracon SI,Knapp MJ,Berghoff WG,et al. Alzheimer Disease and Associated Disorders . 1998
[5]
A randomized trial evaluating the efficacy and safety of rivastigmine tartarate, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease. Corey-Bloom J,Anand R,Veach J. J Geriatr Psychopharmacol . 1998
[6]
The efficacy of Ginkgo biloba on cognitive function in Alzheimer’s disease. Oken BS,Storzbach DM,Kaye JA. Archives of Neurology . 1998
[7]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[8]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[9]
A 12-month,randomized, placebo-controlled trial of propentofylline in patients with dementia according to DSM Ⅲ-R. Macusson J,Rother M,Kittner B,et al. Dementia and Geriatric Cognitive Disorders . 1997
[10]
The effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer’s disease. Bodick NC,Offen WW,Levey AI,et al. Archives of Neurology . 1997